Altria Group (MO) Challenges FDA Review System as Smoke-Free Strategy Takes Center Stage
Covered in this story
What has happened since
- Altria is up 6.9% since this was published, 52 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Altria
- Jefferies: $67 → $60 by Oct 2027 · Underperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Altria →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.